NOVOCURE LTD. 2023-2024 Proxy Voting Records

Description as filed by funds: Election of Directors: Allyson Ocean

NOVOCURE LTD.’s own tally for this item (“Elect Director: Allyson Ocean”): 70,077,497 for, 823,634 against, per its Form 8-K filed June 10, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The ten nominees for election to the Company's Board of Directors were elected as directors to hold office until the Company's 2025 Annual Meeting of Shareholders or until their successors are duly elected and qualified or until their offices are vacated, based upon the following votes:”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 61 asset managers below reported 39,320,817 for.

Showing the 25 largest of 61 asset managers. See all 61 in the interactive database.

Description as filed by funds: Election of Directors: Asaf Danziger

NOVOCURE LTD.’s own tally for this item (“Elect Director: Asaf Danziger”): 70,361,825 for, 548,389 against, per its Form 8-K filed June 10, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The ten nominees for election to the Company's Board of Directors were elected as directors to hold office until the Company's 2025 Annual Meeting of Shareholders or until their successors are duly elected and qualified or until their offices are vacated, based upon the following votes:”
Support: 99.2% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 61 asset managers below reported 39,320,817 for.

Showing the 25 largest of 61 asset managers. See all 61 in the interactive database.

Description as filed by funds: Election of Directors: David Hung

NOVOCURE LTD.’s own tally for this item (“Elect Director: David Hung”): 70,045,127 for, 855,755 against, per its Form 8-K filed June 10, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The ten nominees for election to the Company's Board of Directors were elected as directors to hold office until the Company's 2025 Annual Meeting of Shareholders or until their successors are duly elected and qualified or until their offices are vacated, based upon the following votes:”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 61 asset managers below reported 39,320,817 for.

Showing the 25 largest of 61 asset managers. See all 61 in the interactive database.

Description as filed by funds: Election of Directors: Jeryl Hilleman

NOVOCURE LTD.’s own tally for this item (“Elect Director: Jeryl Hilleman”): 69,730,284 for, 1,170,038 against, per its Form 8-K filed June 10, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The ten nominees for election to the Company's Board of Directors were elected as directors to hold office until the Company's 2025 Annual Meeting of Shareholders or until their successors are duly elected and qualified or until their offices are vacated, based upon the following votes:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 61 asset managers below reported 39,320,817 for.

Showing the 25 largest of 61 asset managers. See all 61 in the interactive database.

Description as filed by funds: Election of Directors: Kinyip Gabriel Leung

NOVOCURE LTD.’s own tally for this item (“Elect Director: Kinyip Gabriel Leung”): 69,753,586 for, 1,145,400 against, per its Form 8-K filed June 10, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The ten nominees for election to the Company's Board of Directors were elected as directors to hold office until the Company's 2025 Annual Meeting of Shareholders or until their successors are duly elected and qualified or until their offices are vacated, based upon the following votes:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 61 asset managers below reported 39,249,461 for, 71,356 against.

Showing the 25 largest of 61 asset managers. See all 61 in the interactive database.

Description as filed by funds: Election of Directors: Kristin Stafford

NOVOCURE LTD.’s own tally for this item (“Elect Director: Kristin Stafford”): 70,144,236 for, 753,901 against, per its Form 8-K filed June 10, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The ten nominees for election to the Company's Board of Directors were elected as directors to hold office until the Company's 2025 Annual Meeting of Shareholders or until their successors are duly elected and qualified or until their offices are vacated, based upon the following votes:”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 61 asset managers below reported 39,276,351 for, 44,466 against.

Showing the 25 largest of 61 asset managers. See all 61 in the interactive database.

Description as filed by funds: Election of Directors: Martin Madden

NOVOCURE LTD.’s own tally for this item (“Elect Director: Martin Madden”): 70,142,778 for, 755,904 against, per its Form 8-K filed June 10, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The ten nominees for election to the Company's Board of Directors were elected as directors to hold office until the Company's 2025 Annual Meeting of Shareholders or until their successors are duly elected and qualified or until their offices are vacated, based upon the following votes:”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 61 asset managers below reported 39,276,351 for, 44,466 against.

Showing the 25 largest of 61 asset managers. See all 61 in the interactive database.

Description as filed by funds: Election of Directors: Timothy Scannell

NOVOCURE LTD.’s own tally for this item (“Elect Director: Timothy Scannell”): 69,587,252 for, 1,312,248 against, per its Form 8-K filed June 10, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The ten nominees for election to the Company's Board of Directors were elected as directors to hold office until the Company's 2025 Annual Meeting of Shareholders or until their successors are duly elected and qualified or until their offices are vacated, based upon the following votes:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 61 asset managers below reported 39,285,017 for, 35,800 against.

Showing the 25 largest of 61 asset managers. See all 61 in the interactive database.

Description as filed by funds: Election of Directors: William Doyle

NOVOCURE LTD.’s own tally for this item (“Elect Director: William Doyle”): 68,652,398 for, 2,260,141 against, per its Form 8-K filed June 10, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The ten nominees for election to the Company's Board of Directors were elected as directors to hold office until the Company's 2025 Annual Meeting of Shareholders or until their successors are duly elected and qualified or until their offices are vacated, based upon the following votes:”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 61 asset managers below reported 39,317,708 for, 3,109 against.

Showing the 25 largest of 61 asset managers. See all 61 in the interactive database.

Description as filed by funds: Election of Directors: William Vernon

NOVOCURE LTD.’s own tally for this item (“Elect Director: William Vernon”): 69,737,079 for, 1,159,965 against, per its Form 8-K filed June 10, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The ten nominees for election to the Company's Board of Directors were elected as directors to hold office until the Company's 2025 Annual Meeting of Shareholders or until their successors are duly elected and qualified or until their offices are vacated, based upon the following votes:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 61 asset managers below reported 39,249,461 for, 71,356 against.

Showing the 25 largest of 61 asset managers. See all 61 in the interactive database.

Description as filed by funds: The Approval of our 2024 Omnibus Incentive Plan

NOVOCURE LTD.’s own tally for this item (“4. Approval of the Company's 2024 Omnibus Incentive Plan”): 60,124,649 for, 10,769,110 against — passed, per its Form 8-K filed June 10, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The proposal to approve the Company's 2024 Omnibus Incentive Plan was approved as an ordinary resolution based upon the following votes:”
Support: 85% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 60 managers: 37,471,204 for, 1,849,538 against. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 3 managers: 586,473 for.

Description as filed by funds: A non-binding advisory vote to approve executive compensation.

NOVOCURE LTD.’s own tally for this item (“3. Approval of a non-binding advisory vote to approve executive compensation”): 69,640,399 for, 1,248,234 against — passed, per its Form 8-K filed June 10, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The proposal to approve executive compensation on a non-binding advisory basis was approved as an ordinary resolution based upon the following votes:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of NOVOCURE LTD.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Advisory Vote to Ratify Named Executive Officers' Compensation” (4 managers, 388,343 for, 2,688 against).

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 60 managers: 39,320,742 for. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 221 managers: 52,215,562 for, 259,937 against, 7,401 abstained, 47 not voted, 632,450 1 year. Showing the 25 largest; see all in the interactive database.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports, all 39 managers: 37,831,003 1 year, 3,109 3 year. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 104 managers: 70,542 for, 44,604,350 1 year, 24,951 3 year. Showing the 25 largest; see all in the interactive database.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports, all 21 managers: 1,459,718 1 year, 26,912 unknown.

Institutional-manager reports, all 107 managers: 6,967 for, 47 not voted, 7,003,750 1 year, 690 3 year, 75 unknown. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: The approval and ratification of the appointment, by the Audit Committee of our Board of Directors, of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, as the auditor and independent registered public accounting firm of the Company for the Company's fiscal year ending December 31, 2024

NOVOCURE LTD.’s own tally for this item (“2. Ratification of Independent Registered Public Accounting Firm”): 80,124,844 for, 5,653,621 against — passed, per its Form 8-K filed June 10, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The proposal to approve and ratify the appointment, by the Audit Committee of the Company's Board of Directors, of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, as the auditor and independent registered public accounting firm of the Company for the fiscal year ending December 31, …”
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 61 asset managers below reported 39,274,654 for, 46,163 against.

Showing the 25 largest of 61 asset managers. See all 61 in the interactive database.